These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6412785)

  • 21. [Forms of the specific immune response in tuberculosis and their relationship to the morphological characteristics of the process].
    Knoring BE; Chuzhova NM; Otten TF; Raskina ES
    Probl Tuberk; 1980 Apr; (4):47-51. PubMed ID: 6770366
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunity and pathogenesis of tuberculosis.
    Ortona L; Cauda R
    Rays; 1998; 23(1):55-63. PubMed ID: 9673135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving new vaccines for tuberculosis through the regulatory process.
    Brennan MJ
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S247-9. PubMed ID: 10875792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunity status of pulmonary tuberculosis patients excreting drug-resistant Mycobacterium tuberculosis].
    Chukanov VI; Kuz'mina NV
    Probl Tuberk; 1996; (1):17-9. PubMed ID: 8907476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.
    Hingley-Wilson SM; Sambandamurthy VK; Jacobs WR
    Nat Immunol; 2003 Oct; 4(10):949-55. PubMed ID: 14515128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse and guinea pig models for testing new tuberculosis vaccines.
    Orme IM
    Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunity parameters in children with prior intrathoracic tuberculosis].
    Elufimova VF; Mitinskaia LA; Iukhimenko NV; Romanova RIu; Abramova ZP; Dem'ianenko NV; Baenskiĭ AV
    Probl Tuberk; 2000; (2):23-5. PubMed ID: 10838903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis: vaccine and drug development.
    Mitsuyama M; McMurray DN
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S10-3. PubMed ID: 17616481
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
    Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa; Ariél' BM; Knoring BE; Skvortsova LA; Vasil'eva GIu; Vishnevskiĭ BI; Pogodaeva SS
    Probl Tuberk Bolezn Legk; 2008; (12):22-7. PubMed ID: 19230184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functions of T-cell subsets and cytokines in mycobacterial infections.
    Munk ME; Emoto M
    Eur Respir J Suppl; 1995 Sep; 20():668s-675s. PubMed ID: 8590567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis: a problem with persistence.
    Stewart GR; Robertson BD; Young DB
    Nat Rev Microbiol; 2003 Nov; 1(2):97-105. PubMed ID: 15035039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection.
    Bhatt K; Uzelac A; Mathur S; McBride A; Potian J; Salgame P
    J Immunol; 2009 Mar; 182(6):3793-800. PubMed ID: 19265158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunological changes caused by Mycobacterium tuberculosis in patients with different blood groups].
    Sybirna RI; Platonova IL; Sakhelashvili MI
    Mikrobiol Z; 1999; 61(4):54-8. PubMed ID: 10565151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD27 contributes to the early systemic immune response to Mycobacterium tuberculosis infection but does not affect outcome.
    Wieland CW; Kerver ME; Florquin S; Nolte MA; Borst J; van Lier R; van Oers MH; van der Poll T
    Int Immunol; 2006 Nov; 18(11):1531-9. PubMed ID: 16966496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins.
    Jeon BY; Kim HJ; Kim SC; Jo EK; Park JK; Paik TH; Kim SJ; Cho SN
    Scand J Immunol; 2008 Jan; 67(1):18-23. PubMed ID: 18021187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cell-mediated immunity and active pulmonary tuberculosis (author's transl)].
    Kennes B; Delespesse G; Duchateau J; Govaerts A; Collet H; Sternon J
    Acta Tuberc Pneumol Belg; 1974; 65(5):429-37. PubMed ID: 4466338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.